Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
This Week in The Journal

This Week in The Journal

Teresa Esch [Ph.D.]
Journal of Neuroscience 29 July 2020, 40 (31) 5893; DOI: https://doi.org/10.1523/JNEUROSCI.twij.40.31.2020
Teresa Esch
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Alzheimer's-Linked SORLA Protein and Neurite Growth

Jessica Stupack, Xiao-Peng Xiong,Lu-Lin Jiang, Tongmei Zhang,Lisa Zhou, et al.

(see pages 5908–5921)

Membrane-associated proteins are constantly moving in cells: from the Golgi to the plasma membrane, from the plasma membrane to endosomes, and from endosomes back to the Golgi, lysosomes, or nucleus. Trafficking of proteins to their proper destination is achieved by various sorting proteins, including sortilin-related receptor with A-type repeats (SORLA). Cargoes guided by SORLA include amyloid precursor protein (APP), which is processed in different cellular compartments to produce β-amyloid and/or other cleavage products. SORLA directs APP away from endosomes, preventing excess production of β-amyloid. Disruption of this role likely explains why reduced SORLA function is associated with Alzheimer's disease. But disruption of other SORLA functions may also contribute to the disease. For example, SORLA is involved in trafficking TrkB, which mediates the beneficial effects of brain-derived neurotrophic factor. And Stupack et al. now reveal a role for SORLA in promoting neurite growth.

SORLA-overexpressing hippocampal neurons grew longer neurites than wild-type neurons in culture, and after a pipette tip was used to mechanically wound cultured cortical neurons, neurites from SORLA-overexpressing neurons grew more quickly into the wound area. Because previous work had shown that SORLA can be cleaved at the plasma membrane to release a soluble fragment extracellularly, the authors asked whether this soluble fragment was responsible for the effects on neurite growth. Indeed, purified soluble SORLA produced by transfected HEK cells enhanced neurite growth in wild-type hippocampal and cortical neurons. Increases in neurite extension were accompanied by increased phosphorylation of the epidermal growth factor receptor (EGFR) and several kinases downstream of this receptor, including ERK and MAP kinases. Furthermore, EGFR coimmunoprecipitated with soluble SORLA. In addition, soluble SORLA increased nuclear levels of the immediate early gene Fos, which promotes neurite outgrowth. Notably, inhibiting EGFR and/or a MAP kinase kinase inhibited the effects of soluble SORLA on neurite outgrowth and Fos translocation.

These results indicate soluble SORLA, which lacks cytoplasmic sequences involved in sorting, stimulates neurite growth and regeneration by increasing activation of EGFR. Loss of this regenerative function might exacerbate the detrimental effects of increased β-amyloid production when SORLA function is reduced.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Soluble SORLA promotes neurite regeneration in cultured cortical neurons after wound injury. Neurons were stained for tubulin (green), F-actin (red), and DAPI (blue). See Stupack et al. for details.

Striatal Cholinergic Interneurons in Parkinson's Disease

Cassandra Avila, Aaron Kucinski, and Martin Sarter

(see pages 6049–6067)

Parkinson's disease (PD) is characterized by slowed movements, resting tremor, and muscle stiffness, sometimes accompanied in the later stages by gait and balance disturbances and an increased risk of falling. Although loss of dopaminergic input from the substantia nigra to the striatum is the root cause of PD, disruption of cholinergic signaling also contributes to the symptoms. Striatal cholinergic interneurons become hyperactive as PD progresses, and because acetylcholine and dopamine exert opposite effects on striatal output, cholinergic hyperactivity is thought to exacerbate the effects of dopamine loss (Liu, 2020, Acta Pharmacol Sin 41:453). In contrast, gait and balance disturbances might result from loss of cholinergic input from the basal forebrain to the cortex, which provides excitatory drive to the striatum. Consistent with this, double-lesion rats, in which both dopaminergic projections and basal forebrain cholinergic neurons are killed, fall more often when walking on a rotating beam than rats with single lesions. The increase in falling has been attributed to loss of attention to sensory cues required to perform the task.

Avila et al. now report that inhibition of striatal cholinergic interneurons also impairs performance on the beam-walking task, as well as on a newly developed cued turning task. In the latter task, rats were trained to walk on a treadmill and to turn and walk in the opposite direction when an auditory or visual cue was presented. Double-lesion rats were less likely to turn in response to the cue than controls. Notably, however, activation of a generally excitatory designer receptor expressed selectively in striatal cholinergic interneurons of double-lesion rats reduced falls on the rotating beam and increased cued turn rates on the treadmill. In contrast, activating a generally inhibitory designer receptor in striatal cholinergic interneurons increased falls and reduced cued turning in rats with intact dopaminergic projections and forebrain cholinergic neurons.

These data suggest that loss of striatal cholinergic interneurons increases falls and disrupts turning in response to cues. Both effects might be explained by a reduced ability to use sensory input to shape motor control. Notably, striatal cholinergic interneurons are lost in the late stages of PD, which might explain why falls increase as the disease progresses.

Footnotes

  • This Week in The Journal was written by Teresa Esch, Ph.D.

Back to top

In this issue

The Journal of Neuroscience: 40 (31)
Journal of Neuroscience
Vol. 40, Issue 31
29 Jul 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
This Week in The Journal
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
This Week in The Journal
Journal of Neuroscience 29 July 2020, 40 (31) 5893; DOI: 10.1523/JNEUROSCI.twij.40.31.2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
This Week in The Journal
Journal of Neuroscience 29 July 2020, 40 (31) 5893; DOI: 10.1523/JNEUROSCI.twij.40.31.2020
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Alzheimer's-Linked SORLA Protein and Neurite Growth
    • Striatal Cholinergic Interneurons in Parkinson's Disease
    • Footnotes
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • This Week in The Journal
  • This Week in The Journal
  • This Week in The Journal
Show more This Week in The Journal
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.